Literature DB >> 14796

The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.

D M Broadhead, J Butterworth.   

Abstract

1. Cases of Gaucher's disease could not be distinguished from controls by the assay of beta-glucosidase activity in water homogenates of liver using 4-methylumbelliferyl-beta-D glucopyranoside. 2. Two peaks of beta-glucosidase activity were separated by Sephadex G-150 gel filtration in control and Gaucher livers. In the presence of the elution buffer pH profiles of peak I showed a deficiency at pH 3.5-4.5 in Gaucher's disease. Gaucher and control peak II had similar pH profiles with little or no activity at pH 3.0-4.0. 3. A clear distinction between homogenates of Gaucher and control liver was obtained by assay at pH 4.0 in the presence of elution buffer, or of sodium chloride, a component of the elution buffer.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14796     DOI: 10.1016/0009-8981(77)90512-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.

Authors:  Y Ben-Yoseph; H L Nadler
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

2.  A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide.

Authors:  Omid Motabar; Ehud Goldin; William Leister; Ke Liu; Noel Southall; Wenwei Huang; Juan J Marugan; Ellen Sidransky; Wei Zheng
Journal:  Anal Bioanal Chem       Date:  2011-10-28       Impact factor: 4.142

3.  Diagnosis of Gaucher's disease in cultured skin fibroblasts and leucocytes.

Authors:  J Butterworth; D M Broadhead
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

4.  Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.

Authors:  S S Raghavan; J Topol; E H Kolodny
Journal:  Am J Hum Genet       Date:  1980-03       Impact factor: 11.025

5.  Isoenzymes of membrane-bound beta-glucosidase of human spleen.

Authors:  M Yaqoob; M Carroll
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

6.  Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.

Authors:  F Y Choy; R G Davidson
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.